Literature DB >> 23597878

Electroconvulsive stimulation reverses anhedonia and cognitive impairments in rats exposed to chronic mild stress.

K Henningsen1, D P D Woldbye, O Wiborg.   

Abstract

Electroconvulsive therapy remains the most effective treatment for depression including a fast onset of action. However, this therapeutic approach suffers from some potential drawbacks. In the acute phase this includes amnesia. Electroconvulsive stimulation (ECS) has previously been shown to reverse a depression-like state in the chronic mild stress model of depression (CMS), but the effect of ECS on cognition has not previously been investigated. In this study the CMS model was used to induce a depressive-like condition in rats. The study was designed to investigate the acute effect of ECS treatment on working memory and the chronic effect of repeated ECS treatments on depression-like behavior and working memory. The results indicated that, in the acute phase, ECS treatment induced a working memory deficit in healthy controls unexposed to stress, while repeated treatments reversed stress-induced decline in working memory, as well as recovering rats submitted to the CMS paradigm from the anhedonic-like state. Like in the clinical setting, a single ECS exposure was ineffective in inducing remission from a depression-like state.
Copyright © 2013 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Anhedonia; Chronic mild stress; Cognitive impairment; Depression; ECT; Electroconvulsive stimulation

Mesh:

Substances:

Year:  2013        PMID: 23597878     DOI: 10.1016/j.euroneuro.2013.03.011

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  5 in total

1.  Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

Authors:  Helena M Abelaira; Thayse Rosa; Airam B de Moura; Natalia M Andrade; Nicoly S Martinello; Larissa R Maciel; Maria Eduarda M Botelho; Laura A Borba; Beatriz C Chede; Camila O Arent; Larissa Joaquim; Sandra Bonfante; Lucinéia G Danielski; Talita Tuon; Fabricia Petronilho; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

2.  Attenuation of social interaction-associated ultrasonic vocalizations and spatial working memory performance in rats exposed to chronic unpredictable stress.

Authors:  Muhammad S Riaz; Martin O Bohlen; Barak W Gunter; Henry Quentin; Craig A Stockmeier; Ian A Paul
Journal:  Physiol Behav       Date:  2015-09-11

Review 3.  Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease.

Authors:  Flavie Darcet; Alain M Gardier; Raphael Gaillard; Denis J David; Jean-Philippe Guilloux
Journal:  Pharmaceuticals (Basel)       Date:  2016-02-17

4.  P11 promoter methylation predicts the antidepressant effect of electroconvulsive therapy.

Authors:  Alexandra Neyazi; Wiebke Theilmann; Claudia Brandt; Tomi Rantamäki; Nobuaki Matsui; Mathias Rhein; Johannes Kornhuber; Malek Bajbouj; Wolfgang Sperling; Stefan Bleich; Helge Frieling; Wolfgang Löscher
Journal:  Transl Psychiatry       Date:  2018-01-22       Impact factor: 6.222

Review 5.  Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives.

Authors:  Tatyana Strekalova; Yanzhi Liu; Daniel Kiselev; Sharafuddin Khairuddin; Jennifer Lok Yu Chiu; Justin Lam; Ying-Shing Chan; Dmitrii Pavlov; Andrey Proshin; Klaus-Peter Lesch; Daniel C Anthony; Lee Wei Lim
Journal:  Psychopharmacology (Berl)       Date:  2022-01-24       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.